glutathione assay protocol GSH/GSSG-Glo™ | Measure Ratio of GSH to GSSG Size and Gauge:28 Gauge, 1 cc, 1/2" Inch (12.7mm)

BPC-157 South Africa | Doctor-Scripted Peptide | BioLux

Contraindications Hydroxocobalamin injections may not be appropriate for individuals with a known hypersensitivity to cobalamin or any component of the formulation

online

Size and Gauge:28 Gauge, 1 cc, 1/2" Inch (12.7mm)

The clinical profiles that make a supervised trial reasonable include: For Semax: Adults with documented cognitive concerns — persistent brain fog, memory complaints, executive dysfunction — that have been worked up to rule out reversible causes (thyroid, insulin resistance, B12 deficiency, sleep disorders) Individuals recovering from neurological insult where BDNF upregulation has clinical rationale High-performance adults seeking evidence-informed cognitive support under physician supervision For Selank: Adults with documented anxiety — particularly GAD patterns — who have had poor tolerability with standard anxiolytics or want to avoid benzodiazepine dependency Individuals experiencing stress-related cognitive impairment: mental fatigue under load, working memory degradation under pressure Patients in whom anxiety and cognitive performance deficits are co-occurring Neither compound should be used: Without a baseline laboratory workup ruling out metabolic drivers of cognitive symptoms (insulin resistance and cognitive function are directly connected — see Meto's Insulin Resistance & Prediabetes program for why this baseline matters) During pregnancy or in patients with active psychiatric conditions requiring established pharmacotherapy Without discussion of the current regulatory status and sourcing pathway with a qualified clinician For a complete guide to baseline labs before any peptide protocol, see How to Start Growth Hormone Peptide Therapy: What Labs to Order First — the pre-protocol framework applies broadly across peptide classes